PuSH - Publication Server of Helmholtz Zentrum München

Chen, J.* ; Sathiaseelan, V.* ; Moore, A.D.* ; Tan, S.* ; Chilamakuri, C.S.* ; Roamio Franklin, V.N.* ; Shahsavari, A.* ; Jakwerth, C.A. ; Hake, S.B.* ; Warren, A.J.* ; Mohorianu, I.* ; D'Santos, C.S.* ; Ringshausen, I.*

ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia.

Blood 137, 3629-3640 (2021)
Publ. Version/Full Text Postprint DOI
Open Access Green
The expression of ZAP-70 in a subset of CLL patients strongly correlates with a more aggressive clinical course, though the exact underlying mechanisms remain elusive. The ability of ZAP-70 to enhance B cell receptor (BCR) signaling, independently of its kinase function, is considered to contribute. Here we employed RNA-sequencing and proteomic analyses of primary cells differing only in their expression of ZAP-70 to further define how ZAP-70 increases aggressiveness of CLL. We identified that ZAP-70 is directly required for cell survival in the absence of an overt BCR signal, which can compensate for ZAP-70 deficiency as an anti-apoptotic signal. In addition, the expression of ZAP-70 regulates the transcription of factors regulating recruitment and activation of T cells, such as CCL3, CCL4 and IL4I1. Quantitative mass spectrometry of double-cross linked ZAP-70 complexes further demonstrated constitutive and direct protein-protein interactions between ZAP-70 and BCR-signaling components. Unexpectedly, ZAP-70 also binds to ribosomal proteins, which is not dependent on, but further increased by BCR-stimulation. Importantly, decreased expression of ZAP-70 significantly reduced MYC-expression and global protein synthesis, providing evidence that ZAP-70 contributes to translational dysregulation in CLL. In conclusion, ZAP-70 constitutively promotes cell survival, microenvironment-interactions and protein synthesis in CLL cells, likely to improve cellular fitness and to further drive disease progression.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords B-cell-receptor; C-myc; Cll; Mutations; Subtype
ISSN (print) / ISBN 0006-4971
e-ISSN 1528-0020
Journal Blood
Quellenangaben Volume: 137, Issue: 26, Pages: 3629-3640 Article Number: , Supplement: ,
Publisher American Society of Hematology
Publishing Place 2021 L St Nw, Suite 900, Washington, Dc 20036 Usa
Reviewing status Peer reviewed
Grants European Cooperation in Science and Technology Action "European Network for Innovative Diagnosis and treatment of Chronic Neutropenias"
Cancer Research UK (CRUK)
Specialist Programme from Blood Cancer UK
UK Medical Research Council
Kay Kendall Leukaemia Fund
Wellcome strategic award
Connor Wright Project
Cambridge National Institute for Health Research Biomedical Research Centre
Kay Kendell Foundation